International multicenter retrospective analysis of thiotepa-based autologous stem cell transplantation for secondary central nervous system lymphoma

Ngā tūemi rite

• International multicenter retrospective analysis of thiotepa-based autologous stem cell transplantation for secondary central nervous system lymphoma
  mā: Jahanzaib Khwaja, me ētahi atu.
  I whakaputaina: (2022-10-01)
• Methotrexate, cytarabine, thiotepa and rituximab (MATRix) chemoimmunotherapy for primary central nervous system lymphoma: a Toronto experience
  mā: Adam Suleman, me ētahi atu.
  I whakaputaina: (2022-12-01)
• Prevention and management of secondary central nervous system lymphoma
  mā: Sabela Bobillo, me ētahi atu.
  I whakaputaina: (2022-11-01)
• Prolonged third complete remission after busulfan, thiotepa, and autologous stem cell transplant in a primary central nervous system lymphoma patient
  mā: Vincent Camus, me ētahi atu.
  I whakaputaina: (2018-08-01)
• Case report: Successful treatment of a patient with relapsed/refractory primary central nervous system lymphoma with thiotepa-based induction, autologous stem cell transplantation and maintenance
  mā: Luyao Wang, me ētahi atu.
  I whakaputaina: (2024-01-01)